Ci Private Wealth, LLC Precision Biosciences Inc Transaction History

Ci Private Wealth, LLC

  • $69.4 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
BUY
$0.29 - $0.45 $45,925 - $71,264
158,365 Added 229.0%
227,521 $81,000
Q3 2023

Nov 03, 2023
BUY
$0.34 - $0.69 $142 - $288
418 Added 0.61%
69,156 $23,000
Q2 2023

Aug 10, 2023
SELL
$0.52 - $0.91 $217 - $380
-418 Reduced 0.6%
68,738 $36,000
Q1 2023

May 15, 2023
BUY
$0.7 - $1.41 $38,875 - $78,305
55,536 Added 407.75%
69,156 $51,000
Q4 2022

Feb 15, 2023
BUY
$0.97 - $45.0 $13,211 - $612,900
13,620 New
13,620 $16,000

Others Institutions Holding DTIL

# of Institutions
7
Shares Held
2.56M
Call Options Held
0
Put Options Held
0
View Full List

About PRECISION BIOSCIENCES INC

DTIL Quotes by TradingView
  • Ticker DTIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 110,818,000
  • Market Cap $584M
  • Description
  • Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...
More about DTIL
Track This Portfolio

Track Ci Private Wealth, LLC Portfolio

Follow Ci Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ci Private Wealth, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email